Extracorporeal Shock Wave Therapy With or Without Kinesiotaping for Plantar Fasciitis
Condition(s) studied
Investigational drug(s) / intervention(s)
Kinesio Taping: Kinesiology tape applied twice (once a week for 2 weeks) with mechanical correction and tension
Extracorporeal Shock Wave Therapy (ESWT): Patients will receive 3 sessions of focused ESWT at 1-week intervals (1800 to 2000 impulses per session at 0.20-0.30 mJ/mm²
Study summary
This study aims to evaluate and compare the short- and mid-term effects of Extracorporeal Shock Wave Therapy (ESWT) alone versus a combination of ESWT and Kinesio Taping (KT) on pain, foot functionality, and plantar fascia thickness in patients with plantar fasciitis.
A total of 48 patients with chronic plantar fasciitis will be included in this prospective, randomized controlled trial and randomly allocated into two groups: the ESWT group and the ESWT + Kinesio Taping group.
Primary outcome measures include pain severity assessed via the Visual Analog Scale (VAS) for morning and general pain, foot functionality evaluated using the Foot Function Index (FFI), and plantar fascia thickness measured via ultrasonography. Evaluations will be conducted at baseline, immediately post-treatment, and at the 3-month follow-up.
Eligibility
Primary outcome measure(s)
- Change in Visual Analog Scale (VAS) Score for Pain — Baseline, immediately post-treatment, and at 3-month follow-up
- Change in Foot Function Index (FFI) Score — Baseline, immediately post-treatment, and at 3-month follow-up
- Change in Plantar Fascia Thickness Measured by Ultrasonography — Baseline, immediately post-treatment, and at 3-month follow-up
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ankara Bilkent City Hospital | Ankara | Çankaya | Recruiting |
More Ankara City Hospital Bilkent trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07864948 on ClinicalTrials.gov ↗ ← All trials in Turkey